Home » Topics » Regulatory » Patents

Patents
RSS

SS Pharm. presents new AGE inhibitors for use in diabetic complications

April 26, 1999

Selective 5-HT1A ligands described by ADIR in recent patent

April 26, 1999

BASF claims series with mixed ETA/ETB-antagonist properties

April 26, 1999

HDL-increasing compounds claimed by AHP for cardiovascular disease, dyslipoproteinemia

April 26, 1999

Hybridon describes mixed-backbone anti-MDM2 antisense oligonucleotide active in vivo

April 23, 1999

Moxonidine metabolite synthesized by Lilly and assessed in SHR

April 23, 1999

Potent and selective COX-2 inhibitors described in recent patent literature by Novartis

April 23, 1999

Merck & Co. discovers new series with antithrombin effects

April 23, 1999

SmithKline Beecham synthesizes pharmaceutically active integrin receptor antagonists

April 23, 1999

CXCR receptor antagonists in development at SB for chemokine-mediated disorders

April 23, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...